Home Biosimilar Antibodies Others CD markers antibody Tepoditamab (Anti-CLEC12A / CD371) For research use only.
Not for use in humans.

Tepoditamab (Anti-CLEC12A / CD371)

Synonyms: MCLA 117

Tepoditamab (Anti-CLEC12A / CD371) is a bispecific monoclonal antibody that targets and binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Tepoditamab kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research. MW: 145.5 KD.

Tepoditamab (Anti-CLEC12A / CD371)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Tepoditamab (Anti-CLEC12A / CD371) is a bispecific monoclonal antibody that targets and binds to CLEC12A of myeloid cells and CD3 of cytotoxic T cells. Tepoditamab kills AML leukaemia mother cells and AML leukaemia stem cells, induces T cell-mediated proliferative lysis of AML cells and can be used in acute myeloid leukaemia (AML) research. MW: 145.5 KD.

Product Details

CAS No. 2044679-53-8
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Tepoditamab (Anti-CLEC12A / CD371) | Tepoditamab (Anti-CLEC12A / CD371) supplier | purchase Tepoditamab (Anti-CLEC12A / CD371) | Tepoditamab (Anti-CLEC12A / CD371) cost | Tepoditamab (Anti-CLEC12A / CD371) manufacturer | order Tepoditamab (Anti-CLEC12A / CD371) | Tepoditamab (Anti-CLEC12A / CD371) distributor